Integrity Hospice Medicare Approved Location: 2351 North 400 East, Suite 121, North Logan, Utah 84341 Phone: (435) 752-6600 |
News Archive
Using the gene-editing tool CRISPR/Cas9, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, have reprogrammed mutated rod photoreceptors to become functioning cone photoreceptors, reversing cellular degeneration and restoring visual function in two mouse models of retinitis pigmentosa.
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City has found that atrial fibrillation patients who are on blood thinning medications are at higher risk of developing dementia if their doses are not in the optimal recommended range.
Scientists are reporting that so-called "thirdhand smoke" - the invisible remains of cigarette smoke that deposits on carpeting, clothing, furniture and other surfaces - may be even more of a health hazard than previously believed. The study, published in ACS' journal, Environmental Science & Technology, extends the known health risks of tobacco among people who do not smoke but encounter the smoke exhaled by smokers or released by smoldering cigarette butts.
Oncolytics Biotech Inc. announced today that a U.S. Phase I study of REOLYSIN® in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022) is now open to enrollment. The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York.
› Verified 1 days ago